Alaproclate (developmental code name GEA-654) is a drug that was being developed as an antidepressant by the Swedish pharmaceutical company Astra AB (now AstraZeneca) in the 1970s.
Alaproclate (developmental code name GEA-654) is a drug that was being developed in the 1970s by Astra AB (now AstraZeneca) for use as an antidepressant.